$1.96
▼ -2.0% Today
as of Sep 4, 16:46 ET
Last 30 days
Recent Press Releases & News
BioVie completes final patient visit in Phase 2 Long COVID trial
BioVie Announces Completion of Treatment Phase of ADDRESS-LC Trial of Bezisterim for the Treatment of Neurological Symptoms Associated with Long COVID
First Phosphate and BioVie Interviews to Air Nationally on the RedChip Small Stocks, Big Money(TM) Show on CNBC and Bloomberg TV
Overview
52-week range
$0.82
$3.79
38% of range
Avg surprise (last 1)
+53.1%
Avg reaction (last 2)
-2.7%
50% positive
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Mon May 11, 2026 | Mar/2026 | $-0.70 | — | — | -366.7% | -8.2% | earnings |
| Wed Dec 31, 2025 | Dec 2025 | $-0.77 | — | — | — | — | financials |
| Tue Sep 30, 2025 | Sep 2025 | $-0.98 | — | — | — | — | financials |
| Mon May 12, 2025 | Mar/2025 | $-0.15 | $-0.32 | +53.1% | — | +2.7% | earnings |
| Tue Dec 31, 2024 | Dec 2024 | $-4.55 | — | — | — | — | financials |
| Mon Sep 30, 2024 | Sep 2024 | $-7.00 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-2.00 | — | — | — | — | financials |
| Sun Dec 31, 2023 | Dec 2023 | $-2.20 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-2.92 | — | — | — | — | financials |
| Fri Mar 31, 2023 | Mar 2023 | $-0.43 | — | — | — | — | financials |
| Sat Dec 31, 2022 | Dec 2022 | $-0.50 | — | — | — | — | financials |
| Fri Sep 30, 2022 | Sep 2022 | $-0.38 | — | — | — | — | financials |
| Thu Mar 31, 2022 | Mar 2022 | $-0.28 | — | — | — | — | financials |
Financials
Income statement (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $-5M | $-6M | $-5M | — | — | $-7M | $-4M | — |
| Net income | $-5M | — | — | — | — | — | — | — |
| EPS (diluted) | $-0.70 | $-0.77 | $-0.98 | — | — | $-4.55 | $-7.00 | — |
Balance sheet (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $13M | $21M | $25M | $18M | $23M | $24M | $20M | $24M |
| Inventory | — | — | — | — | — | — | — | — |
| Total current assets | $17M | $22M | $26M | $21M | $24M | $25M | $20M | $24M |
| Total assets | $18M | $23M | $27M | $22M | $25M | $26M | $21M | $25M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $2M | $3M | $2M | $3M | $3M | $2M | $7M | $10M |
| Total equity | $16M | — | — | $19M | — | — | — | $16M |
Implied volatility — last 90 days
No IV snapshots yet for BIVI.
IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.